Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI
- PMID: 34603032
- PMCID: PMC8479593
- DOI: 10.3389/fphar.2021.721011
Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI
Abstract
Background: There is no definite effect in the treatment of myocardial ischemia/reperfusion (I/R) injury in patients with acute ST-segment elevation myocardial infarction (STEMI). We evaluated the protective effect of Shexiang Baoxin Pill (SBP) on I/R injury in STEMI patients. Methods: STEMI patients were randomly divided into a primary percutaneous coronary intervention (PPCI) group (n = 52) and a PPCI + SBP group (n = 51). The area at risk of infarction (AAR) and final infarct size (FIS) were examined by single-photon emission computed tomography (SPECT). I/R injury was assessed using myocardial salvage (MS) and salvage index (SI) calculated from AAR and FIS. Results: The ST-segment resolution (STR) in the PPCI + SBP group was significantly higher than that in the PPCI group (p = 0.036), and the peak value of high-sensitivity troponin T (hsTNT) was lower than that in the PPCI group (p = 0.048). FIS in the PPCI + SBP group was smaller than that in the PPCI group (p = 0.047). MS (p = 0.023) and SI (p = 0.006) in the PPCI + SBP group were larger than those in the PPCI group. The left ventricular ejection fraction (LVEF) in the PPCI + SBP group was higher than that in the PPCI group (p = 0.049), and N-terminal pro-B type natriuretic peptide (NT-proBNP) level in the PPCI + SBP group was lower than that in the PPCI group (p = 0.048). Conclusions: SBP can alleviate I/R injury (MS and SI), decrease myocardial infarction area (peak value of hsTNT and FIS), and improve myocardial reperfusion (MBG and STR) and cardiac function (LVEF and NT-proBNP).
Keywords: ST-segment elevation myocardial infarction; myocardial ischemia reperfusion injury; myocardial protection; myocardial salvage; shexiang baoxin pill.
Copyright © 2021 Qin, Li and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Bolognese L., Carrabba N., Parodi G., Santoro G. M., Buonamici P., Cerisano G., et al. (2004). Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome after Primary Coronary Angioplasty for Acute Myocardial Infarction. Circulation 109 (9), 1121–1126. 10.1161/01.CIR.0000118496.44135.A7 - DOI - PubMed
-
- Bøtker H. E., Kharbanda R., Schmidt M. R., Bøttcher M., Kaltoft A. K., Terkelsen C. J., et al. (2010). Remote Ischaemic Conditioning before Hospital Admission, as a Complement to Angioplasty, and Effect on Myocardial Salvage in Patients with Acute Myocardial Infarction: a Randomised Trial. Lancet 27 (9716), 727–734. - PubMed
-
- Du Y., Ge Y., Xu Z., Aa N., Gu X., Meng H., et al. (2018). Hypoxia-Inducible Factor 1 Alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study. Med. Sci. Monit. 24, 8870–8877. 10.12659/MSM.912051 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
